|
J Biol Chem, Vol. 274, Issue 49, 34507-34510, December 3, 1999
MINIREVIEW
Cortical Actin Organization: Lessons from ERM
(Ezrin/Radixin/Moesin) Proteins*
Sachiko
Tsukita §¶ and
Shigenobu
Yonemura§
From the College of Medical Technology, Kyoto
University, Sakyo-ku, Kyoto 606, Japan and § Department of
Cell Biology, Faculty of Medicine, Kyoto University, Sakyo-ku,
Kyoto 606, Japan
 |
INTRODUCTION |
In recent years to clarify the molecular
mechanism of dynamic organization of the cortical actin filaments,
which is important not only for the determination of cell-surface
structures but also for the functions of integral membrane proteins
themselves, various types of submembrane proteins involved in cortical
actin filament/plasma membrane interaction have been intensively studied.
In this minireview, we focus on ezrin/radixin/moesin
(ERM)1 proteins, which are
general cross-linkers between cortical actin filaments and plasma
membranes and are involved in the formation of microvilli, cell
adhesion sites, ruffling membranes, and cleavage furrows. ERM proteins
have attracted a great deal of interest because their functions have
been shown to be regulated by the Rho signaling pathway (for recent
reviews, see Refs. 1-7).
 |
Structure of ERM Proteins |
The ERM family consists of three closely related proteins, ezrin,
radixin, and moesin (ERM proteins) (8) (Fig.
1). Ezrin (~82 kDa) was first isolated
from chicken intestinal brush borders as a component of microvilli (9).
Molecular cloning revealed that ezrin was identical to cytovillin,
which was enriched in microvilli of human placental
syncytiotrophoblasts (10, 11). Radixin (~80 kDa) was isolated from
rat liver as a component of adherens junctions (12). Moesin (~75 kDa)
was isolated from bovine uterus abundant in smooth muscle cells as a
heparin-binding protein (13). Homologues for ERM proteins have been
found from Caenorhabditis elegans to human,
although the number of family members appears to vary from one to three
depending on species (2).

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 1.
ERM family members (ezrin, radixin,
moesin), merlin/ schwannomin, and band 4.1 protein. ERM proteins
consist of three domains: a globular N-terminal membrane-binding domain
(FERM domain or N-ERMAD), followed by an extended -helical domain
and a positively charged C-terminal actin-binding domain (C-ERMAD).
Proteins as well as PIP2 that bind to ERM proteins are
listed at the top (for details, see "Structure of ERM
Proteins"). In some papers on ERM proteins the amino acid residues
are numbered from proline 1, because methionine 1 is
posttranslationally removed in human ezrin and moesin (10, 15). In this
review, however, they are numbered from methionine 1. The percentage
sequence identity with ezrin in each domain is indicated at the amino
acid sequence level.
|
|
The sequences of their N-terminal halves are highly conserved (~85%
identity) and similar to the N-terminal half of human erythroid band
4.1 protein (~78 kDa), indicating that the ERM family is included in
the band 4.1 superfamily that contains merlin/schwannomin (a tumor
suppressor molecule for neurofibromatosis type II), talin, PTP-H1, and
PTP-MEG. Among these, merlin (isoforms I-III)(~70 kDa) is fairly
similar to ERM proteins (~60% identity). The sequence, which is
conserved among the members of the band 4.1 superfamily and referred to
as the FERM (4.1 and ERM) domain, is a membrane-binding site in band
4.1 protein, and similar sequences have recently been found in the
central portion of PTP-BAS and the C-terminal domain of myosin VIIA. In
ERM proteins, the N-terminal FERM domain is followed by an extended
-helical domain and a charged C-terminal domain, which includes a
consensus sequence motif for actin binding. Thus, from their structure,
ERM proteins have been suggested to function as cross-linkers between
actin filaments and plasma membranes (1-7).
 |
Subcellular Distribution and Functions of ERM Proteins |
Immunoblotting analysis and immunofluorescence microscopy revealed
that in most cultured cells all ERM proteins are co-expressed and
co-localized but that in organs their expression and distribution pattern appear to be regulated in a cell type-specific manner (1-7).
Immunofluorescence studies of cultured fibroblasts and epithelial cells
have revealed that ERM proteins are co-expressed and co-concentrated at
cell-surface structures such as microvilli, filopodia, uropods,
ruffling membranes, retraction fibers, and cell adhesion sites where
actin filaments are associated with plasma membranes (8, 14-17) (Fig.
2). ERM proteins are also concentrated
specifically at cleavage furrows in dividing cells (14) but not along
cytoplasmic actin filaments such as stress fibers, in contrast to
filamin and -actinin, which are concentrated in both sites (18).
Suppression of the expression of all ERM proteins with antisense
oligonucleotides in cultured fibroblasts/epithelial cells destroyed
microvillus formation as well as cell-to-cell/cell-to-substrate adhesion (19). Similarly, in cultured neurons that contain mainly radixin and moesin, antisense oligonucleotides of radixin and moesin
severely affected the morphology, motility, and process formation of
growth cones (20). Specific ezrin ablation by MicroCALI (chromatophore-assisted laser irradiation) blocked membrane ruffling and motility (21). Furthermore, overproduction of full-length ERM
proteins appeared to enhance cell adhesion, whereas that of their
C-terminal halves perturbed the cell-surface morphology and inhibited
cytokinesis (22, 23). These findings suggested that ERM proteins were
involved in the formation and/or maintenance of cortical actin
organization through their cross-linking activity between actin
filaments and plasma membranes.

View larger version (65K):
[in this window]
[in a new window]
|
Fig. 2.
Immunofluorescence microscopy of cultured
baby hamster kidney cells with anti-ERM polyclonal antibody. ERM
proteins are co-concentrated at cell-surface structures such as
microvilli (Mv), cell-cell adhesion sites (C-C),
and cleavage furrows (CF) where actin filaments are
associated with plasma membranes. Bar, 20 µm.
|
|
Extensive functional analyses suggested the possible functional
redundancy of ERM proteins at least at the cellular level. Recently,
moesin-deficient mice were generated by gene targeting, and they
appeared normal without any compensatory up-regulation of ezrin or
radixin (24). Therefore, also at the whole body level ERM proteins
appear to be functionally redundant, although ERM proteins are not
necessarily co-localized and co-expressed at the organ level. Targeted
disruption of ezrin and radixin genes will allow clarification of this
redundancy problem in the near future.
 |
Actin and Membrane Binding of ERM Proteins |
The C-terminal halves of ERM proteins bind to F-actin through
their major actin-binding sites, the C-terminal 34 amino acids, which
are highly conserved among these proteins (25). In addition to this
domain, two more actin-binding domains have recently been identified in
their N-terminal and middle regions, which bind to F-actin and both F-
and G-actin, respectively (26). Although the physiological relevance of
these newly identified actin-binding sites in ERM proteins is not clear
at present, the mode of association of actin filaments with ERM
proteins does not appear to be simple. G-actin binding affinity in
their middle regions would explain the actin barbed end-capping
activity of ERM proteins, which was detected in radixin at low ionic
strength (12).
On the other hand, the N-terminal halves of ERM proteins were reported
to directly bind to the cytoplasmic domains of CD44 (27, 28) and other
integral membrane proteins such as ICAM-1, -2, and -3 and CD43, which
were co-localized with ERM proteins in vivo (17, 27-32).
Although the cytoplasmic domains of these integral membrane proteins
have no shared sequences, their juxtamembrane positively charged amino
acid clusters are thought to be responsible for their binding to ERM
proteins (32, 33). This direct binding of ERM proteins with integral
membrane proteins was shown to be essential for cell-surface
morphogenesis such as microvillus formation (34, 35). Ezrin effected
the function of ICAM-2 in thymoma cells for being targeted by natural
killer cells (29).
The mechanism of indirect binding of ERM proteins to integral membrane
proteins has also been reported. EBP-50 (ERM-binding phosphoprotein of
50 kDa) was identified as a cytoplasmic protein, the C-terminal region
of which binds to the N-terminal half of ezrin (36). Sequence analyses
revealed that EBP-50 is identical to a Na+/H+
exchanger regulatory factor (NHE-RF). This NHE-RF and its isoform, E3KARP, bear two PDZ domains, which were shown to directly bind to the
C terminus of NHE3 (36, 37). Thus, NHE-RF and E3KARP can function as
adapters between NHE3 and ezrin (38). Interestingly, because NHE-RF
regulates the NHE3 function in a protein kinase A
(PKA)-dependent manner and because ezrin specifically binds to the RII subunit of PKA (38), ezrin appears to play an important role
in recruiting PKA to the NHE3·NHE-RF complex to regulate the function
of NHE3. Furthermore, NHE-RF and E3KARP were found to also be
associated with other integral membrane proteins such as the
2-adrenergic receptor and the cystic fibrosis
transmembrane conductance regulator (39, 40), which are not always
co-localized with ERM proteins (41). The physiological relevance of the
existence of two mechanisms of binding of ERM proteins to integral
membrane proteins, direct and indirect, is an interesting subject for
future study.
 |
Intramolecular Interdomain Interaction between N- and C-terminal
Halves of ERM Proteins: Molecular Mechanism for Inactivation of ERM
Proteins |
Given that the cortical actin filaments are dynamically organized
in response to various signals, the cross-linking activity of ERM
proteins between actin filaments and plasma membranes is expected to be
dynamically regulated. Indeed, the pioneering work by Bretscher (42) or
Hanzel et al. (43) showed that EGF treatment of A431 cells
or the secretion-stimulation of parietal cells rapidly recruited
substantial amounts of ERM proteins to the cortical actin layer with
concomitant phosphorylation of ERM proteins. When conventionally
cultured cells were homogenized and centrifuged in physiological
saline, ERM proteins were partitioned almost equally into the soluble
and insoluble fractions (44). These findings suggested that there are
active (insoluble) and inactive (soluble) forms of ERM proteins in
terms of their cross-linking activity inside cells.
Evidence has accumulated in vitro and in vivo
that the N- and C-terminal halves of ERM proteins mutually interact
intramolecularly and suppress their actin filament and membrane binding
activities, respectively (45-47). Recently, it was shown that when
two amino acid residues were deleted from the C-terminal end of
ezrin, which do not correspond to the EBP-50-binding domain, the
interdomain interaction was affected, allowing ezrin to directly
interact with EBP-50 (37). These findings indicated that conformational masking by intramolecular interdomain interaction is the molecular mechanism behind the inactivation of ERM proteins.
The region involved in the interdomain interaction was narrowed down to
residues 1-297 and 480-586 (1-296 and 479-585 when methionine 1 is
posttranslationally removed) as exemplified in ezrin, and these regions
are called N- and C-ERMADs (ERM-association domains), respectively
(46). Initially, these N- and C-ERMADs were thought to be responsible
for oligomerization of ERM proteins, i.e. intermolecular
interaction of ERM proteins, but it has been suggested that they are
also important for intramolecular interaction (6, 7). Furthermore,
yeast two-hybrid analyses identified several middle regions between N-
and C-ERMADs that interact with N- and C-ERMADs (48). Although the
molecular mechanism and physiological relevance of dimerization and
oligomerization of ERM proteins remain elusive, it is now accepted that
the intramolecular mutual suppression mechanism keeps ERM proteins in
an inactive state and that some activation signal may release this
suppression to activate ERM proteins inside cells.
 |
Phosphorylation and PIP2 Binding as Activation Signals
of ERM Proteins |
To date, two molecular events have been shown to generate and/or
maintain the active form of ERM proteins in vitro:
phosphorylation of their C-terminal threonine residue and
PIP2 binding to their N-terminal domains. The
phosphorylation of ERM proteins, especially ezrin, has been examined in
detail. EGF stimulation induced tyrosine and serine phosphorylation of
ezrin in A431 cells with concomitant translocation from the cytoplasm
to the cortical actin layer (42). The tyrosine residues that were
phosphorylated in A431 cells were shown to be Tyr-146 and Tyr-354
(Tyr-145 and Tyr-353 when methionine 1 is posttranslationally removed)
in ezrin, the former of which was conserved in radixin and moesin
(49). ERM proteins were also reported to be heavily
tyrosine-phosphorylated by v-Src and hepatocyte growth factor (50, 51).
However, the substitution of Tyr-146 with phenylalanine in ezrin showed
some effects on cell motility but did not affect the cortical
localization of ezrin induced by hepatocyte growth factor. Thus, the
direct activation of ERM proteins by tyrosine phosphorylation is unlikely.
Secretion/stimulation in gastric parietal cells was reported to induce
serine/threonine phosphorylation of ezrin (43). In platelets thrombin
activation induced the phosphorylation of moesin at a specific
C-terminal threonine residue (Thr-558) (52), causing filopodia formation. This site was effectively phosphorylated in
vitro by ROK /ROCK-II/Rho-kinase in radixin (Thr-564) and by PKC- (53, 54). However, it is likely that ROCK kinases do not
phosphorylate ERM proteins in vivo (55). In vitro
functional analyses suggested that the C-terminal threonine
phosphorylation maintains ERM proteins in the active state by
suppressing the intramolecular interaction (53). Immunofluorescence
microscopy with monoclonal antibodies specific for C-terminal
threonine-phosphorylated ERM proteins revealed that ERM proteins
localized beneath plasma membranes were actually phosphorylated at the
C-terminal threonine in vivo (53, 56). Taken all together,
it seems that the threonine phosphorylation just maintains the
activated ERM proteins.
Another candidate for the activation signal for ERM proteins is
PIP2, which has been shown to directly bind to the
N-terminal halves of ERM proteins in vitro (28, 57).
Recently, it has been shown that PIP2 is a key factor for
the activation of ERM proteins in vivo (55).
 |
ERM Proteins Downstream as Well as Upstream of Rho |
The question has thus arisen as to the identities of the upstream
factors required for activation of ERM proteins. Rho, one of the small
GTP-binding proteins, is now considered to be a general regulator of
actin-based cytoskeletal organization. To date, in vitro as
well as in vivo analyses have suggested an intimate
relationship between the Rho signaling pathway and activation of ERM
proteins. First, the binding ability of ERM proteins to the cytoplasmic domain of CD44 in crude cell homogenate was reported to be enhanced by
activation of Rho (28). In semi-permeabilized Swiss 3T3 cells, at least
one of the ERM proteins was shown to be required for Rho-dependent formation of stress fibers and focal
contacts (58). Furthermore, transfection of the constitutively
active mutant of RhoA (V14RhoA), but not that of Rac1 or Cdc42, induced
microvillus formation to which ERM proteins were recruited (55, 59).
Thus, it is now accepted that when Rho is activated in vivo,
ERM proteins in the cytoplasm are activated and recruited to plasma
membranes to form microvilli. Although ERM proteins are also suggested
to be located downstream of Rac (58), the activation of ERM proteins to
form microvilli specifically depends on Rho but not on Rac.
Rho has been reported to activate several serine/threonine
kinases such as ROK /ROCK-II/Rho-kinase, ROK /ROCK-I, citron
kinase, protein kinase N, and protein kinase C1 (58). Immunoblotting with a monoclonal antibody specific for C-terminal
threonine-phosphorylated ERM proteins revealed that in serum-starved
Swiss 3T3 cells Rho activation by lysophosphatidic acid stimulation
increased the levels of the C-terminal threonine phosphorylation of ERM
proteins (53). Rho-kinase, which effectively phosphorylates the
C-terminal threonines of ERM proteins in vitro, is not
responsible for this Rho-dependent threonine
phosphorylation of ERM proteins in vivo.
PIP2-producing phosphatidylinositol 4-phosphate 5-kinase
(PI4P5K) has also been reported to be a direct Rho effector (for a
review, see Ref. 60). Because activation of dormant ERM proteins was
induced by PIP2 in vivo as well as
in vitro (28, 55), one possible pathway for the activation
of ERM proteins is as follows. Rho may activate PI4P5K, which in turn
increases the amount of PIP2. PIP2 then
activates ERM proteins by inhibiting their interdomain interaction,
which allows phosphorylation of their C-terminal threonine residue by
unidentified kinases. The C-terminally threonine-phosphorylated ERM
proteins are stabilized as activated forms, which function as actin
filament/plasma membrane cross-linkers to form microvilli (Fig.
3).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 3.
Activation pathway of ERM proteins. Rho
activates PI4P5K, which increases the amount of PIP2.
PIP2 then activates ERM proteins by inhibiting their
interdomain interaction, which allows phosphorylation of their
C-terminal threonine residue by some kinases. The C-terminally
threonine-phosphorylated ERM proteins are stabilized at the activated
forms, which function as actin filament/plasma membrane cross-linkers
to form microvilli. Activated ERM proteins are associated directly with
the adhesion molecules such as CD44 and ICAM-1, -2, and -3 and
indirectly with other integral membrane proteins such as NHE3 through
EBP-50/NHE-RF. Activated ERM proteins also bind to Rho-GDI at their
N-terminal halves, suppressing GDI activity of Rho-GDI to release
GDP-Rho, which is activated to GTP-Rho. This GTP-Rho can be used to
activate ERM proteins just beneath the plasma membranes, providing a
positive feedback pathway.
|
|
On the other hand, immunoprecipitation experiments identified Rho-GDI
(GDP dissociation inhibitor) in the CD44-ERM protein complex (28). An
in vitro binding study then revealed that active but not
inactive forms of ERM proteins directly bound to Rho-GDI at their
N-terminal halves (61). Interestingly, this binding of ERM proteins
suppressed GDI activity of Rho-GDI, i.e. GDP-Rho was
released from Rho-GDI, followed by activation as GTP-Rho possibly through Dbl (GDP/GTP exchange protein) (61, 62). These findings suggested that ERM proteins, once activated, can activate Rho, which
again activates ERM proteins as a positive feedback system. In this
sense, ERM proteins are located not only downstream but also upstream
of Rho.
 |
Inactivation Signals for ERM Proteins |
Because native monomers of ERM proteins have a tendency to
inactivate themselves by the interdomain interaction, the
down-regulation of activation signals may inactivate ERM proteins
inside cells. For example, at the initial phase of apoptosis, ERM
proteins were dephosphorylated and inactivated, resulting in their
cytoplasmic translocation with concomitant microvillar breakdown (44).
In this process, the C-terminal threonine was confirmed to be
dephosphorylated by the monoclonal antibody specific for C-terminal
threonine-phosphorylated ERM
proteins.2 Recently, myosin
light chain phosphatase was shown to bind to moesin through its
myosin-binding subunit in vitro, although its physiological
relevance remains unclear (63). On the other hand, proteolysis could be
another method of inactivation of ERM proteins because ezrin is a good
substrate for calpain in vitro (6, 7). Although evidence is
still lacking, on and off activation and/or inactivation signals and
their balance may regulate the function of ERM proteins.
 |
ERM Proteins and Merlin |
Some, but not all, of the characteristics of ERM proteins
appear to be shared by merlin. The subcellular localization of ERM proteins was similar to that of merlin in fibroblasts (microvilli and
ruffling membranes) but different in epithelial cells; merlin, but not
ERM proteins, was concentrated at lateral membranes together with
E-cadherin (64). The N-terminal half of merlin bound to the cytoplasmic
domains of CD44 (65) and NHE-RF (66) as well as Rho-GDI in
vitro (64). Merlin has two major alternatively spliced isoforms, I
and II, which differ at their C-terminal ends (67). Although neither of
these C-terminal ends shows any similarity to those of ERM proteins,
the major actin-binding domains, merlin has been reported to bind to
actin filaments at its middle region (68). Interdomain interaction
between the N- and C-terminal halves has been suggested in isoform-I,
but the interaction does not appear to affect its binding affinity to
actin filaments or to NHE-RF (66, 68). No interdomain interaction has
been detected in isoform-II (69).
At present, there are three distinct possible explanations for the
sequence similarity between ERM proteins and merlin. First, it is
possible that merlin functions in cells by competing for shared binding
partners such as CD44, NHE-RF, and Rho-GDI. However, because the molar
ratio of endogenous merlin/ERM was calculated to be 0.05-0.15 in
cultured fibroblasts and epithelial cells, the ERM-merlin competition
is not likely in vivo. Second, merlin would be functionally
redundant for ERM proteins. Data from the suppression experiments of
ERM proteins by antisense oligonucleotides discussed above are
inconsistent with this explanation. Furthermore, this explanation was
not supported by the observation that merlin-deficient mice showed an
embryonic lethal phenotype (70). Third, it is also possible that merlin
shows sequence similarity to ERM proteins because both are involved in
Rho signaling pathways; for example, both bind to Rho-GDI. If this is
the case, loss of function mutations of merlin may induce tumorigenesis
through some disturbance in the Rho signaling pathway. In this
connection, it should be pointed out that neurofibromin, which is
responsible for neurofibromatosis type I, shows GTPase-activating
protein activity for Ras (71). It is reasonable to speculate that both
neurofibromatosis types I and II are caused by some dysregulation of
small GTP-binding protein-dependent signaling pathways.
 |
Perspective |
In the past decade, it has been established that ERM proteins
function as general cross-linkers in the cortical layer, coupled with
signal transduction pathways such as Rho signaling. Because ERM
proteins are expressed almost ubiquitously, this cross-linking system
would be involved in various cellular events in various types of cells.
Thus, in the coming decade, ERM proteins will attract increasing
interest in many fields from not only biological but also medical
researchers. For example, in the immune system ERM proteins are thought
to play an important role in cell recognition of T lymphocytes by
producing uropods (17, 29).
It will also be interesting to study the interactions between ERM
proteins and microtubules. Radixin was characterized as a marginal
microtubule band-associated protein in nucleated erythrocytes (72), and
in activated T-lymphocytes tubulin was co-concentrated at the
uropods together with ERM proteins (17). Furthermore, it was also shown
that ERM proteins have some homology with Tea 1, which is localized on
the ends of microtubules and is critical for polarization in yeast
(73). Further studies of the ERM proteins-microtubule interaction will
provide new insight into the physiological functions of ERM proteins as
well as the cortical actin layer.
 |
FOOTNOTES |
*
This minireview will be reprinted
in the 1999 Minireview Compendium, which
will be available in December, 1999. This is the fourth article of four in the
"Proteins That Regulate Dynamic Actin Remodeling in Response to
Membrane Signaling Minireview Series."
¶
To whom correspondence should be addressed. Tel.:
81-75-753-4373; Fax: 81-75-753-4660; E-mail:
atsukita@mfour.med.kyoto-u.ac.jp.
2
Sa. Tsukita, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
ERM, ezrin/radixin/moesin;
EBP-50, ERM-binding phosphoprotein of 50 kDa;
PTP, protein-tyrosine phosphatase;
NHE-RF, Na+/H+ exchanger regulatory factor;
PKA, protein kinase A;
ERMAD, ERM-association domain;
PIP2, phosphatidylinositol 4,5-bisphosphate;
GTP S, guanosine
5'-O-(3-thio)triphosphate;
PI4P5K, phosphatidylinositol
4-phosphate 5-kinase;
GDI, GDP dissociation inhibitor.
 |
REFERENCES |
| 1.
|
Bretscher, A.,
Reczek, D.,
and Berryman, M.
(1997)
J. Cell Sci.
110,
3011-3018[Abstract]
|
| 2.
|
Tsukita,
Sa,
Yonemura, S.,
Tsukita,
and Sh.
(1997)
Curr. Opin. Cell Biol.
9,
70-75[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Tsukita,
Sa,
Yonemura, S.,
Tsukita,
and Sh.
(1997)
Trends Biochem. Sci.
22,
53-58[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Vaheri, A.,
Carpén, O.,
Heiska, L.,
Helander, T. S.,
Jääskeläinen, J.,
Majander-Nordenswan, P.,
Sainio, M.,
Timonen, T.,
and Turunen, O.
(1997)
Curr. Opin. Cell Biol.
9,
659-666[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
del Pozo, M. A.,
Nieto, M.,
Serrador, J. M.,
Sancho, D.,
Vicente-Manzanares, M.,
Martinez, C.,
and Sanchez-Madrid, F.
(1998)
Cell Adhes. Commun.
6,
125-133[Medline]
[Order article via Infotrieve]
|
| 6.
|
Bretscher, A.
(1999)
Curr. Opin. Cell Biol.
11,
109-116[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Mangeat, P.,
Roy, C.,
and Martin, M.
(1999)
Trends Cell Biol.
9,
187-192[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Sato, N.,
Funayama, N.,
Nagafuchi, A.,
Yonemura, S.,
Tsukita,
Sa,
Tsukita,
and Sh.
(1992)
J. Cell Sci.
103,
131-143[Abstract/Free Full Text]
|
| 9.
|
Bretcher, A.
(1983)
J. Cell Biol.
97,
425-432[Abstract/Free Full Text]
|
| 10.
|
Gould, K. L.,
Bretscher, A.,
Esch, F. S.,
and Hunter, T.
(1989)
EMBO J.
8,
4133-4142[Medline]
[Order article via Infotrieve]
|
| 11.
|
Turunen, O.,
Winqvist, R.,
Pakkanen, R.,
Grzeschik, K.-H.,
Wahlström, T.,
and Vaheri, A.
(1989)
J. Biol. Chem.
264,
16727-16732[Abstract/Free Full Text]
|
| 12.
|
Tsukita,
Sa,
Hieda, Y.,
Tsukita,
and Sh.
(1989)
J. Cell Biol.
108,
2369-2382[Abstract/Free Full Text]
|
| 13.
|
Lankes, W.,
Griesmacher, A.,
Grünwald, J.,
Schwartz-Albiez, R.,
and Keller, R.
(1988)
Biochem. J.
251,
831-842[Medline]
[Order article via Infotrieve]
|
| 14.
|
Sato, N.,
Yonemura, S.,
Obinata, T.,
Tsukita,
Sa,
Tsukita,
and Sh.
(1991)
J. Cell Biol.
113,
321-330[Abstract/Free Full Text]
|
| 15.
|
Franck, Z.,
Gary, R.,
and Bretscher, A.
(1993)
J. Cell Sci.
105,
219-231[Abstract]
|
| 16.
|
Amieva, M. R.,
and Furthmayr, H.
(1995)
Exp. Cell Res.
219,
180-196[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Serrador, J. M.,
Alonso-Lebrero, J. L.,
del Pozo, M. A.,
Furthmayr, H.,
Schwartz-Albiez, R.,
Calvo, J.,
Lozano, F.,
and Sánchez-Madrid, F.
(1997)
J. Cell Biol.
138,
1409-1423[Abstract/Free Full Text]
|
| 18.
|
Nunnally, M. H.,
D'Angelo, J. M.,
and Graig, S. W.
(1980)
J. Cell Biol.
87,
219-226[Abstract/Free Full Text]
|
| 19.
|
Takeuchi, K.,
Sato, N.,
Kasahara, H.,
Funayama, N.,
Nagafuchi, A.,
Yonemura, S.,
Tsukita,
Sa,
Tsukita,
and Sh.
(1994)
J. Cell Biol.
125,
1371-1384[Abstract/Free Full Text]
|
| 20.
|
Paglini, G.,
Kunda, P.,
Quiroga, S.,
Kosik, K.,
and Cáceres, A.
(1998)
J. Cell Biol.
143,
443-455[Abstract/Free Full Text]
|
| 21.
|
Lamb, R. F.,
Ozanne, B. W.,
Roy, C.,
McGarry, L.,
Stipp, C.,
Mangeat, P.,
and Jay, D. G.
(1997)
Curr. Biol.
7,
682-688[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Martin, M.,
Andréoli, C.,
Sahuquet, A.,
Montcourrier, P.,
Algrain, M.,
and Mangeat, P.
(1995)
J. Cell Biol.
128,
1081-1093[Abstract/Free Full Text]
|
| 23.
|
Henry, M. D.,
Agosti, C. G.,
and Solomon, F.
(1995)
J. Cell Biol.
129,
1007-1022[Abstract/Free Full Text]
|
| 24.
|
Doi, Y.,
Itoh, M.,
Yonemura, S.,
Ishihara, S.,
Takano, H.,
Noda, T.,
Tsukita,
Sh,
Tsukita,
and Sa.
(1999)
J. Biol. Chem.
274,
2315-2321[Abstract/Free Full Text]
|
| 25.
|
Turunen, O.,
Wahlström, T.,
and Vaheri, A.
(1994)
J. Cell Biol.
126,
1445-1453[Abstract/Free Full Text]
|
| 26.
|
Roy, C.,
Martin, M.,
and Mangeat, P.
(1997)
J. Biol. Chem.
272,
20088-20095[Abstract/Free Full Text]
|
| 27.
|
Tsukita,
Sa,
Oishi, K.,
Sato, N.,
Sagara, J.,
Kawai, A.,
Tsukita,
and Sh.
(1994)
J. Cell Biol.
126,
391-401[Abstract/Free Full Text]
|
| 28.
|
Hirao, M.,
Sato, N.,
Kondo, T.,
Yonemura, S.,
Monden, M.,
Sasaki, T.,
Takai, Y.,
Tsukita,
Sh,
Tsukita,
and Sa.
(1996)
J. Cell Biol.
135,
37-51[Abstract/Free Full Text]
|
| 29.
|
Helander, T. S.,
Carpén, O.,
Turunen, O.,
Kovanen, P. E.,
Vaheri, A.,
and Timmonen, T.
(1996)
Nature
382,
265-268[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Heiska, L.,
Alfthan, K.,
Grönholm, M.,
Vilja, P.,
Vaheri, A.,
and Carpén, O.
(1998)
J. Biol. Chem.
273,
21893-21900[Abstract/Free Full Text]
|
| 31.
|
Yonemura, S.,
Nagafuchi, A.,
Sato, N.,
Tsukita,
and Sh.
(1993)
J. Cell Biol.
120,
437-449[Abstract/Free Full Text]
|
| 32.
|
Yonemura, S.,
Hirao, M.,
Doi, Y.,
Takahashi, N.,
Kondo, T.,
Tsukita,
Sa,
Tsukita,
and Sh.
(1998)
J. Cell Biol.
140,
885-895[Abstract/Free Full Text]
|
| 33.
|
Legg, J. W.,
and Isacke, C. M.
(1998)
Curr. Biol.
8,
705-708[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Yonemura, S.,
Tsukita,
Sa,
Tsukita,
and Sh.
(1999)
J. Cell Biol.
145,
1497-1509[Abstract/Free Full Text]
|
| 35.
|
Kenney, D.,
Cairns, L.,
Remold-O'Donnell, E.,
Peterson, J.,
Rosen, F. S.,
and Parkman, R.
(1986)
Blood
68,
1329-1332[Abstract/Free Full Text]
|
| 36.
|
Reczek, D.,
Berryman, M.,
and Bretscher, A.
(1997)
J. Cell Biol.
139,
169-179[Abstract/Free Full Text]
|
| 37.
|
Reczek, D.,
and Bretscher, A.
(1998)
J. Biol. Chem.
273,
18452-18458[Abstract/Free Full Text]
|
| 38.
|
Dransfield, D. T.,
Bradford, A. J.,
Smith, J.,
Martin, M.,
Roy, C.,
Mangeat, P. H.,
and Goldenring, J. R.
(1997)
EMBO J.
16,
35-43[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Hall, R. A.,
Premont, R. T.,
Chow, C.-W.,
Blitzer, J. T.,
Pitcher, J. A.,
Claing, A.,
Stoffel, R. H.,
Barak, L. S.,
Shenolikar, S.,
Weinman, E. J.,
Grinstein, S.,
and Lefkowitz, R. J.
(1998)
Nature
392,
626-630[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Short, D. B.,
Trotter, K. W.,
Reczek, D.,
Kreda, S. M.,
Bretscher, A.,
Boucher, R. C.,
Stutts, M. J.,
and Milgram, S. L.
(1998)
J. Biol. Chem.
273,
19797-19801[Abstract/Free Full Text]
|
| 41.
|
Moyer, B. D.,
Loffing, J.,
Schweibert, E. M.,
Loffing-Cueni, D.,
Halpin, P. A.,
Karlson, K. H.,
Ismailov, I. I.,
Guggino, W. B.,
Langford, G. M.,
and Stanton, B. A.
(1998)
J. Biol. Chem.
273,
21759-21768[Abstract/Free Full Text]
|
| 42.
|
Bretscher, A.
(1989)
J. Cell Biol.
108,
921-930[Abstract/Free Full Text]
|
| 43.
|
Hanzel, D. K.,
Urushidani, T.,
Usinger, W. R.,
Smolka, A.,
and Forte, J. G.
(1989)
Am. J. Physiol.
256,
G1082-G1089[Abstract/Free Full Text]
|
| 44.
|
Kondo, T.,
Takeuchi, K.,
Doi, Y.,
Yonemura, S.,
Nagata, S.,
Tsukita,
Sh,
Tsukita,
and Sa.
(1997)
J. Cell Biol.
139,
749-758[Abstract/Free Full Text]
|
| 45.
|
Andréoli, C.,
Martin, M.,
Le Borgne, R.,
Reggio, H.,
and Mangeat, P.
(1994)
J. Cell Sci.
107,
2509-2521[Abstract]
|
| 46.
|
Gary, R.,
and Bretscher, A.
(1995)
Mol. Biol. Cell
6,
1061-1075[Abstract]
|
| 47.
|
Magendantz, M.,
Henry, M. D.,
Lander, A.,
and Solomon, F.
(1995)
J. Biol. Chem.
270,
25324-25327[Abstract/Free Full Text]
|
| 48.
|
Bhartur, S. G.,
and Goldenring, J. R.
(1998)
Biochem. Biophys. Res. Commun.
243,
874-877[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
| Krieg, J. & Hunter, T. (1992) 267, 19258-19265
|
| 50.
|
Takeda, H.,
Nagafuchi, A.,
Yonemura, S.,
Tsukita,
Sa,
Behrens, J.,
Birchmeier, W.,
Tsukita,
and Sh.
(1995)
J. Cell Biol.
131,
1839-1847[Abstract/Free Full Text]
|
| 51.
|
Crepaldi, T.,
Gautreau, A.,
Comoglio, P. M.,
Louvard, D.,
and Arpin, M.
(1997)
J. Cell Biol.
138,
423-434[Abstract/Free Full Text]
|
| 52.
|
Nakamura, F.,
Amieva, M. R.,
and Furthmayr, H.
(1995)
J. Biol. Chem.
270,
31377-31385[Abstract/Free Full Text]
|
| 53.
|
Matsui, T.,
Maeda, M.,
Doi, Y.,
Yonemura, S.,
Amano, M.,
Kaibuchi, K.,
Tsukita,
Sa,
Tsukita,
and Sh.
(1998)
J. Cell Biol.
140,
647-657[Abstract/Free Full Text]
|
| 54.
|
Pietromonaco, S. F.,
Simons, P. C.,
Altman, A.,
and Elias, L.
(1998)
J. Biol. Chem.
273,
7594-7603[Abstract/Free Full Text]
|
| 55.
|
Matsui, T.,
Yonemura, S.,
Tsukita,
Sh,
Tsukita,
and Sa.
(1999)
Curr. Biol.
9,
1259-1262[CrossRef][Medline]
[Order article via Infotrieve]
|
| 56.
|
Hayashi, K.,
Yonemura, S.,
Matsui, T.,
Tsukita,
Sa,
Tsukita,
and Sh.
(1999)
J. Cell Sci.
112,
1149-1158[Abstract]
|
| 57.
|
Niggli, V.,
Andréoli, C.,
Roy, C.,
and Mangeat, P.
(1995)
FEBS Lett.
376,
172-176[CrossRef][Medline]
[Order article via Infotrieve]
|
| 58.
|
Mackay, D. J.,
and Hall, A.
(1998)
J. Biol. Chem.
273,
20685-20686[Free Full Text]
|
| 59.
|
Shaw, R. J.,
Henry, M.,
Solomon, F.,
and Jacks, T.
(1998)
Mol. Biol. Cell
9,
403-419[Abstract/Free Full Text]
|
| 60.
|
Ren, X.-D.,
and Schwartz, M. A.
(1998)
Curr. Opin. Genet. Dev.
8,
63-67[CrossRef][Medline]
[Order article via Infotrieve]
|
| 61.
|
Takahashi, K.,
Sasaki, T.,
Mammoto, A.,
Takaishi, K.,
Kameyama, T.,
Tsukita,
Sa,
Tsukita,
Sh,
and Takai, Y.
(1997)
J. Biol. Chem.
272,
23371-23375[Abstract/Free Full Text]
|
| 62.
|
Takahashi, K.,
Sasaki, T.,
Mammoto, A.,
Hotta, I.,
Takaishi, K.,
Imamura, H.,
Nakano, K.,
Kodama, A.,
and Takai, Y.
(1998)
Oncogene
16,
3279-3284[CrossRef][Medline]
[Order article via Infotrieve]
|
| 63.
|
Fukata, Y.,
Kimura, K.,
Oshiro, N.,
Saya, H.,
Matsuura, Y.,
and Kaibuchi, K.
(1998)
J. Cell Biol.
141,
409-418[Abstract/Free Full Text]
|
| 64.
|
Maeda, M.,
Matsui, T.,
Imamura, M.,
Tsukita,
Sh,
Tsukita,
and Sa.
(1999)
Oncogene
18,
4788-4797[CrossRef][Medline]
[Order article via Infotrieve]
|
| 65.
|
Sainio, M.,
Zhao, F.,
Heiska, L.,
Turunen, O.,
den Bakker, M.,
Zwarthoff, E.,
Lutchman, M.,
Rouleau, G. A.,
Jääskeläinen, J.,
Vaheri, A.,
and Carpén, O.
(1997)
J. Cell Sci.
110,
2249-2260[Abstract]
|
| 66.
|
Murthy, A.,
Gonzalez-Agosti, C.,
Cordero, E.,
Pinney, D.,
Candia, C.,
Solomon, F.,
Gusella, J.,
and Ramesh, V.
(1998)
J. Biol. Chem.
273,
1273-1276[Abstract/Free Full Text]
|
| 67.
|
Hara, T.,
Bianchi, A. B.,
Seizinger, B. R.,
and Kley, N.
(1994)
Cancer Res.
54,
330-335[Abstract/Free Full Text]
|
| 68.
|
Xu, H.-M.,
and Gutmann, D. H.
(1998)
J. Neurosci. Res.
51,
403-415[CrossRef][Medline]
[Order article via Infotrieve]
|
| 69.
|
Sherman, L.,
Xu, H.-M.,
Geist, R. T.,
Saporito-Irwin, S.,
Howells, N.,
Ponta, H.,
Herrlich, P.,
and Gutmann, D. H.
(1997)
Oncogene
15,
2505-2509[CrossRef][Medline]
[Order article via Infotrieve]
|
| 70.
|
McClatchey, A. I.,
Saotome, I.,
Mercer, K.,
Crowley, D.,
Gusella, J. F.,
Bronson, R. T.,
and Jacks, T.
(1998)
Genes Dev.
12,
1121-1133[Abstract/Free Full Text]
|
| 71.
|
Xu, G. F.,
O'Connell, P.,
Viskochil, D.,
Cawthon, R.,
Robertson, M.,
Culver, M.,
Dunn, D.,
Stevens, J.,
Gesteland, R.,
White, R.,
and Weiss, R.
(1990)
Cell
62,
599-608[CrossRef][Medline]
[Order article via Infotrieve]
|
| 72.
|
Birgbauer, E.,
and Solomon, F.
(1989)
J. Cell Biol.
109,
1609-1620[Abstract/Free Full Text]
|
| 73.
|
Vega, L. R.,
and Solomon, F.
(1997)
Cell
89,
825-828[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. P. F. Nuesch, S. Bar, S. Lachmann, and J. Rommelaere
Ezrin-Radixin-Moesin Family Proteins Are Involved in Parvovirus Replication and Spreading
J. Virol.,
June 1, 2009;
83(11):
5854 - 5863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Loftus, Z. Yang, N. L. Tran, J. Kloss, C. Viso, M. E. Berens, and C. A. Lipinski
The Pyk2 FERM domain as a target to inhibit glioma migration
Mol. Cancer Ther.,
June 1, 2009;
8(6):
1505 - 1514.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Wakayama, H. Nakata, M. Kurobo, Y. Sai, and S. Iseki
Expression, Localization, and Binding Activity of the Ezrin/Radixin/Moesin Proteins in the Mouse Testis
J. Histochem. Cytochem.,
April 1, 2009;
57(4):
351 - 362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chevrier, C. Genton, A. Kallies, A. Karnowski, L. A. Otten, B. Malissen, M. Malissen, M. Botto, L. M. Corcoran, S. L. Nutt, et al.
CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche
PNAS,
March 10, 2009;
106(10):
3895 - 3900.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sadakata, H. Okazawa, T. Sato, Y. Supriatna, H. Ohnishi, S. Kusakari, Y. Murata, T. Ito, U. Nishiyama, T. Minegishi, et al.
SAP-1 is a microvillus-specific protein tyrosine phosphatase that modulates intestinal tumorigenesis
Genes Cells,
March 1, 2009;
14(3):
295 - 308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Takamatsu, J. L. Espinoza, X. Lu, Z. Qi, K. Okawa, and S. Nakao
Anti-Moesin Antibodies in the Serum of Patients with Aplastic Anemia Stimulate Peripheral Blood Mononuclear Cells to Secrete TNF-{alpha} and IFN-{gamma}
J. Immunol.,
January 1, 2009;
182(1):
703 - 710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hebert, S. Potin, M. Sebbagh, J. Bertoglio, J. Breard, and J. Hamelin
Rho-ROCK-Dependent Ezrin-Radixin-Moesin Phosphorylation Regulates Fas-Mediated Apoptosis in Jurkat Cells
J. Immunol.,
November 1, 2008;
181(9):
5963 - 5973.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Mori, K. Kitano, S.-i. Terawaki, R. Maesaki, Y. Fukami, and T. Hakoshima
Structural Basis for CD44 Recognition by ERM Proteins
J. Biol. Chem.,
October 24, 2008;
283(43):
29602 - 29612.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Hashimoto, F. Amaya, H. Matsuyama, H. Ueno, S. Kikuchi, M. Tanaka, Y. Watanabe, M. Ebina, A. Ishizaka, S. Tsukita, et al.
Dysregulation of lung injury and repair in moesin-deficient mice treated with intratracheal bleomycin
Am J Physiol Lung Cell Mol Physiol,
October 1, 2008;
295(4):
L566 - L574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Schelling and B. G. Abu Jawdeh
Regulation of cell survival by Na+/H+ exchanger-1
Am J Physiol Renal Physiol,
September 1, 2008;
295(3):
F625 - F632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Ruan, C. T. Lee, and J. Desbarats
A Novel Juxtamembrane Domain in Tumor Necrosis Factor Receptor Superfamily Molecules Activates Rac1 and Controls Neurite Growth
Mol. Biol. Cell,
August 1, 2008;
19(8):
3192 - 3202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Haedicke, K. de los Santos, S. P. Goff, and M. H. Naghavi
The Ezrin-Radixin-Moesin Family Member Ezrin Regulates Stable Microtubule Formation and Retroviral Infection
J. Virol.,
May 1, 2008;
82(9):
4665 - 4670.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Uawithya, T. Pisitkun, B. E. Ruttenberg, and M. A. Knepper
Transcriptional profiling of native inner medullary collecting duct cells from rat kidney
Physiol Genomics,
January 17, 2008;
32(2):
229 - 253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Swanson, D. D. Crane, and H. D. Caldwell
Chlamydia trachomatis Species-Specific Induction of Ezrin Tyrosine Phosphorylation Functions in Pathogen Entry
Infect. Immun.,
December 1, 2007;
75(12):
5669 - 5677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Takai, K. Kitano, S.-i. Terawaki, R. Maesaki, and T. Hakoshima
Structural basis of PSGL-1 binding to ERM proteins.
Genes Cells,
December 1, 2007;
12(12):
1329 - 1338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Csortos, I. Kolosova, and A. D. Verin
Regulation of vascular endothelial cell barrier function and cytoskeleton structure by protein phosphatases of the PPP family
Am J Physiol Lung Cell Mol Physiol,
October 1, 2007;
293(4):
L843 - L854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Furutani, H. Matsuno, M. Kawasaki, T. Sasaki, K. Mori, and Y. Yoshihara
Interaction between Telencephalin and ERM Family Proteins Mediates Dendritic Filopodia Formation
J. Neurosci.,
August 15, 2007;
27(33):
8866 - 8876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-i. Terawaki, K. Kitano, and T. Hakoshima
Structural Basis for Type II Membrane Protein Binding by ERM Proteins Revealed by the Radixin-neutral Endopeptidase 24.11 (NEP) Complex
J. Biol. Chem.,
July 6, 2007;
282(27):
19854 - 19862.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Besse, S. Mertel, R. J. Kittel, C. Wichmann, T. M. Rasse, S. J. Sigrist, and A. Ephrussi
The Ig cell adhesion molecule Basigin controls compartmentalization and vesicle release at Drosophila melanogaster synapses
J. Cell Biol.,
June 21, 2007;
177(5):
843 - 855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Lee, N. F. Silva-Gagliardi, U. Tepass, C. J. McGlade, and K. V. Anderson
The FERM protein Epb4.1l5 is required for organization of the neural plate and for the epithelial-mesenchymal transition at the primitive streak of the mouse embryo
Development,
June 1, 2007;
134(11):
2007 - 2016.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chateauvieux, J.-L. Ichante, B. Delorme, V. Frouin, G. Pietu, A. Langonne, N. Gallay, L. Sensebe, M. T. Martin, K. A. Moore, et al.
Molecular profile of mouse stromal mesenchymal stem cells
Physiol Genomics,
April 24, 2007;
29(2):
128 - 138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Tamma, G. Procino, M. Svelto, and G. Valenti
Hypotonicity causes actin reorganization and recruitment of the actin-binding ERM protein moesin in membrane protrusions in collecting duct principal cells
Am J Physiol Cell Physiol,
April 1, 2007;
292(4):
C1476 - C1484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hatzoglou, I. Ader, A. Splingard, J. Flanders, E. Saade, I. Leroy, S. Traver, S. Aresta, and J. de Gunzburg
Gem Associates with Ezrin and Acts via the Rho-GAP Protein Gmip to Down-Regulate the Rho Pathway
Mol. Biol. Cell,
April 1, 2007;
18(4):
1242 - 1252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Takamatsu, X. Feng, T. Chuhjo, X. Lu, C. Sugimori, K. Okawa, M. Yamamoto, S. Iseki, and S. Nakao
Specific antibodies to moesin, a membrane-cytoskeleton linker protein, are frequently detected in patients with acquired aplastic anemia
Blood,
March 15, 2007;
109(6):
2514 - 2520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. LaGier, S. H. Yoo, E. C. Alfonso, S. Meiners, and M. E. Fini
Inhibition of Human Corneal Epithelial Production of Fibrotic Mediator TGF-{beta}2 by Basement Membrane-Like Extracellular Matrix
Invest. Ophthalmol. Vis. Sci.,
March 1, 2007;
48(3):
1061 - 1071.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Chiba, N. Sakai, M. Murata, M. Osanai, T. Ninomiya, T. Kojima, and N. Sawada
The nuclear receptor hepatocyte nuclear factor 4{alpha} acts as a morphogen to induce the formation of microvilli
J. Cell Biol.,
December 18, 2006;
175(6):
971 - 980.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Nukada, N. Okamoto, S. Konakahara, K. Tezuka, K. Ohashi, K. Mizuno, and T. Tsuji
AILIM/ICOS-mediated elongation of activated T cells is regulated by both the PI3-kinase/Akt and Rho family cascade
Int. Immunol.,
December 1, 2006;
18(12):
1815 - 1824.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Martin-Villar, D. Megias, S. Castel, M. M. Yurrita, S. Vilaro, and M. Quintanilla
Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition
J. Cell Sci.,
November 1, 2006;
119(21):
4541 - 4553.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Simoncini, C. Scorticati, P. Mannella, A. Fadiel, M. S. Giretti, X.-D. Fu, C. Baldacci, S. Garibaldi, A. Caruso, L. Fornari, et al.
Estrogen Receptor {alpha} Interacts with G{alpha}13 to Drive Actin Remodeling and Endothelial Cell Migration via the RhoA/Rho Kinase/Moesin Pathway
Mol. Endocrinol.,
August 1, 2006;
20(8):
1756 - 1771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sala-Valdes, A. Ursa, S. Charrin, E. Rubinstein, M. E. Hemler, F. Sanchez-Madrid, and M. Yanez-Mo
EWI-2 and EWI-F Link the Tetraspanin Web to the Actin Cytoskeleton through Their Direct Association with Ezrin-Radixin-Moesin Proteins
J. Biol. Chem.,
July 14, 2006;
281(28):
19665 - 19675.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Grimsley, M. Lu, L. B. Haney, J. M. Kinchen, and K. S. Ravichandran
Characterization of a Novel Interaction between ELMO1 and ERM Proteins
J. Biol. Chem.,
March 3, 2006;
281(9):
5928 - 5937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Mehta and A. B. Malik
Signaling Mechanisms Regulating Endothelial Permeability
Physiol Rev,
January 1, 2006;
86(1):
279 - 367.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ratnikov, C. Ptak, J. Han, J. Shabanowitz, D. F. Hunt, and M. H. Ginsberg
Talin phosphorylation sites mapped by mass spectrometry
J. Cell Sci.,
November 1, 2005;
118(21):
4921 - 4923.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Komiya, M. Shimizu, J. Ikenouchi, S. Yonemura, T. Matsui, Y. Fukunaga, H. Liu, F. Endo, S. Tsukita, and A. Nagafuchi
Apical membrane and junctional complex formation during simple epithelial cell differentiation of F9 cells
Genes Cells,
November 1, 2005;
10(11):
1065 - 1080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Cybulsky, T. Takano, J. Papillon, K. Bijian, and J. Guillemette
Activation of the extracellular signal-regulated kinase by complement C5b-9
Am J Physiol Renal Physiol,
September 1, 2005;
289(3):
F593 - F603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Tamma, E. Klussmann, J. Oehlke, E. Krause, W. Rosenthal, M. Svelto, and G. Valenti
Actin remodeling requires ERM function to facilitate AQP2 apical targeting
J. Cell Sci.,
August 15, 2005;
118(16):
3623 - 3630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tamura, S. Kikuchi, M. Hata, T. Katsuno, T. Matsui, H. Hayashi, Y. Suzuki, T. Noda, S. Tsukita, and S. Tsukita
Achlorhydria by ezrin knockdown: defects in the formation/expansion of apical canaliculi in gastric parietal cells
J. Cell Biol.,
April 11, 2005;
169(1):
21 - 28.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Zhang, X. Tian, P. Chandra, and K. L. R. Brouwer
Role of Glycosylation in Trafficking of Mrp2 in Sandwich-Cultured Rat Hepatocytes
Mol. Pharmacol.,
April 1, 2005;
67(4):
1334 - 1341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Heiska and O. Carpen
Src Phosphorylates Ezrin at Tyrosine 477 and Induces a Phosphospecific Association between Ezrin and a Kelch-Repeat Protein Family Member
J. Biol. Chem.,
March 18, 2005;
280(11):
10244 - 10252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ma, J. Zhou, S. Fan, L. Wang, X. Li, Q. Yan, M. Zhou, H. Liu, Q. Zhang, H. Zhou, et al.
Role of a novel EGF-like domain-containing gene NGX6 in cell adhesion modulation in nasopharyngeal carcinoma cells
Carcinogenesis,
February 1, 2005;
26(2):
281 - 291.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yokoyama, H. Goto, I. Izawa, H. Mizutani, and M. Inagaki
Aurora-B and Rho-kinase/ROCK, the two cleavage furrow kinases, independently regulate the progression of cytokinesis: possible existence of a novel cleavage furrow kinase phosphorylates ezrin/radixin/moesin (ERM)
Genes Cells,
February 1, 2005;
10(2):
127 - 137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-H. Lee, T. Katakai, T. Hara, H. Gonda, M. Sugai, and A. Shimizu
Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation
J. Cell Biol.,
October 25, 2004;
167(2):
327 - 337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Nijhara, P. B. van Hennik, M. L Gignac, M. J. Kruhlak, P. L. Hordijk, J. Delon, and S. Shaw
Rac1 Mediates Collapse of Microvilli on Chemokine-Activated T Lymphocytes
J. Immunol.,
October 15, 2004;
173(8):
4985 - 4993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-i. Kitajiri, K. Fukumoto, M. Hata, H. Sasaki, T. Katsuno, T. Nakagawa, J. Ito, S. Tsukita, and S. Tsukita
Radixin deficiency causes deafness associated with progressive degeneration of cochlear stereocilia
J. Cell Biol.,
August 16, 2004;
166(4):
559 - 570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ivetic, O. Florey, J. Deka, D. O. Haskard, A. Ager, and A. J. Ridley
Mutagenesis of the Ezrin-Radixin-Moesin Binding Domain of L-selectin Tail Affects Shedding, Microvillar Positioning, and Leukocyte Tethering
J. Biol. Chem.,
August 6, 2004;
279(32):
33263 - 33272.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Takenouchi, N. Kiyokawa, T. Taguchi, J. Matsui, Y. U. Katagiri, H. Okita, K. Okuda, and J. Fujimoto
Shiga toxin binding to globotriaosyl ceramide induces intracellular signals that mediate cytoskeleton remodeling in human renal carcinoma-derived cells
J. Cell Sci.,
August 1, 2004;
117(17):
3911 - 3922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhao, H. Shiue, S. Palkon, Y. Wang, P. Cullinan, J. K. Burkhardt, M. W. Musch, E. B. Chang, and J. R. Turner
Ezrin regulates NHE3 translocation and activation after Na+-glucose cotransport
PNAS,
June 22, 2004;
101(25):
9485 - 9490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Finnerty, D. Chambers, J. Ingraffea, H. R. Faber, P. A. Karplus, and A. Bretscher
The EBP50-moesin interaction involves a binding site regulated by direct masking on the FERM domain
J. Cell Sci.,
March 15, 2004;
117(8):
1547 - 1552.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Matsumoto, T. Daikoku, H. Wang, E. Sato, and S.K. Dey
Differential Expression of Ezrin/Radixin/Moesin (ERM) and ERM-Associated Adhesion Molecules in the Blastocyst and Uterus Suggests Their Functions During Implantation
Biol Reprod,
March 1, 2004;
70(3):
729 - 736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Cybulsky, T. Takano, J. Papillon, A. Khadir, K. Bijian, and L. Le Berre
The actin cytoskeleton facilitates complement-mediated activation of cytosolic phospholipase A2
Am J Physiol Renal Physiol,
March 1, 2004;
286(3):
F466 - F476.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F. Pataky, R. Pironkova, and A. J. Hudspeth
Radixin is a constituent of stereocilia in hair cells
PNAS,
February 24, 2004;
101(8):
2601 - 2606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kobayashi, J. Sagara, H. Kurita, M. Morifuji, M. Ohishi, K. Kurashina, and S.'i. Taniguchi
Clinical Significance of Cellular Distribution of Moesin in Patients with Oral Squamous Cell Carcinoma
Clin. Cancer Res.,
January 15, 2004;
10(2):
572 - 580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Brown, R. Nijhara, J. A. Hallam, M. Gignac, K. M. Yamada, S. L. Erlandsen, J. Delon, M. Kruhlak, and S. Shaw
Chemokine stimulation of human peripheral blood T lymphocytes induces rapid dephosphorylation of ERM proteins, which facilitates loss of microvilli and polarization
Blood,
December 1, 2003;
102(12):
3890 - 3899.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. C. Bornhauser, P.-A. Olsson, and D. Lindholm
MSAP Is a Novel MIR-interacting Protein That Enhances Neurite Outgrowth and Increases Myosin Regulatory Light Chain
J. Biol. Chem.,
September 12, 2003;
278(37):
35412 - 35420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Miyamoto, J. Yamauchi, and H. Itoh
Src Kinase Regulates the Activation of a Novel FGD-1-related Cdc42 Guanine Nucleotide Exchange Factor in the Signaling Pathway from the Endothelin A Receptor to JNK
J. Biol. Chem.,
August 8, 2003;
278(32):
29890 - 29900.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Potter, A. Srirangam, K. A. Fiacco, D. Brocks, J. Hawes, C. Herndon, M. Maki, D. Acheson, and I. M. Herman
Calpain Regulates Enterocyte Brush Border Actin Assembly and Pathogenic Escherichia coli-mediated Effacement
J. Biol. Chem.,
August 8, 2003;
278(32):
30403 - 30412.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Chellaiah, R. S. Biswas, S. R. Rittling, D. T. Denhardt, and K. A. Hruska
Rho-dependent Rho Kinase Activation Increases CD44 Surface Expression and Bone Resorption in Osteoclasts
J. Biol. Chem.,
August 1, 2003;
278(31):
29086 - 29097.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. McRobert, M. Gallicchio, G. Jerums, M. E. Cooper, and L. A. Bach
The Amino-terminal Domains of the Ezrin, Radixin, and Moesin (ERM) Proteins Bind Advanced Glycation End Products, an Interaction That May Play a Role in the Development of Diabetic Complications
J. Biol. Chem.,
July 3, 2003;
278(28):
25783 - 25789.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Jobard, B. Bouadjar, F. Caux, S. Hadj-Rabia, C. Has, F. Matsuda, J. Weissenbach, M. Lathrop, J.-F. Prud'homme, and J. Fischer
Identification of mutations in a new gene encoding a FERM family protein with a pleckstrin homology domain in Kindler syndrome
Hum. Mol. Genet.,
April 15, 2003;
12(8):
925 - 935.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. E. McCann, B. Vanherberghen, K. Eleme, L. M. Carlin, R. J. Newsam, D. Goulding, and D. M. Davis
The Size of the Synaptic Cleft and Distinct Distributions of Filamentous Actin, Ezrin, CD43, and CD45 at Activating and Inhibitory Human NK Cell Immune Synapses
J. Immunol.,
March 15, 2003;
170(6):
2862 - 2870.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Smith, N. Nassar, A. Bretscher, R. A. Cerione, and P. A. Karplus
Structure of the Active N-terminal Domain of Ezrin. CONFORMATIONAL AND MOBILITY CHANGES IDENTIFY KEYSTONE INTERACTIONS
J. Biol. Chem.,
February 7, 2003;
278(7):
4949 - 4956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Samstag, S. M. Eibert, M. Klemke, and G. H. Wabnitz
Actin cytoskeletal dynamics in T lymphocyte activation and migration
J. Leukoc. Biol.,
January 1, 2003;
73(1):
30 - 48.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Orian-Rousseau, L. Chen, J. P. Sleeman, P. Herrlich, and H. Ponta
CD44 is required for two consecutive steps in HGF/c-Met signaling
Genes & Dev.,
December 1, 2002;
16(23):
3074 - 3086.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kubo, T. Yamashita, A. Yamaguchi, H. Sumimoto, K. Hosokawa, and M. Tohyama
A Novel FERM Domain Including Guanine Nucleotide Exchange Factor Is Involved in Rac Signaling and Regulates Neurite Remodeling
J. Neurosci.,
October 1, 2002;
22(19):
8504 - 8513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Medina, J. Williams, E. Klipfell, D. Zarnescu, G. Thomas, and A. Le Bivic
Crumbs interacts with moesin and {beta}Heavy-spectrin in the apical membrane skeleton of Drosophila
J. Cell Biol.,
September 3, 2002;
158(5):
941 - 951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Sako, M. Nakao, K. Nakaya, H. Yamasaki, B. Gottstein, M. W. Lightowers, P. M. Schantz, and A. Ito
Alveolar Echinococcosis: Characterization of Diagnostic Antigen Em18 and Serological Evaluation of Recombinant Em18
J. Clin. Microbiol.,
August 1, 2002;
40(8):
2760 - 2765.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Mitchem, E. Hibbard, L. A. Beyer, K. Bosom, G. A. Dootz, D. F. Dolan, K. R. Johnson, Y. Raphael, and D. C. Kohrman
Mutation of the novel gene Tmie results in sensory cell defects in the inner ear of spinner, a mouse model of human hearing loss DFNB6
Hum. Mol. Genet.,
August 1, 2002;
11(16):
1887 - 1898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yonemura, T. Matsui, S. Tsukita, and S. Tsukita
Rho-dependent and -independent activation mechanisms of ezrin/radixin/moesin proteins: an essential role for polyphosphoinositides in vivo
J. Cell Sci.,
June 15, 2002;
115(12):
2569 - 2580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. G. Ponimaskin, J. Profirovic, R. Vaiskunaite, D. W. Richter, and T. A. Voyno-Yasenetskaya
5-Hydroxytryptamine 4(a) Receptor Is Coupled to the Galpha Subunit of Heterotrimeric G13 Protein
J. Biol. Chem.,
May 31, 2002;
277(23):
20812 - 20819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Benvenuti, R. Cramer, C. C. Quinn, J. Bruce, M. Zvelebil, S. Corless, J. Bond, A. Yang, S. Hockfield, A. L. Burlingame, et al.
Differential Proteome Analysis of Replicative Senescence in Rat Embryo Fibroblasts
Mol. Cell. Proteomics,
April 1, 2002;
1(4):
280 - 292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Shimizu, A. Seto, N. Maita, K. Hamada, S. Tsukita, S. Tsukita, and T. Hakoshima
Structural Basis for Neurofibromatosis Type 2. CRYSTAL STRUCTURE OF THE MERLIN FERM DOMAIN
J. Biol. Chem.,
March 15, 2002;
277(12):
10332 - 10336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Serrador, M. Vicente-Manzanares, J. Calvo, O. Barreiro, M. C. Montoya, R. Schwartz-Albiez, H. Furthmayr, F. Lozano, and F. Sanchez-Madrid
A Novel Serine-rich Motif in the Intercellular Adhesion Molecule 3 Is Critical for Its Ezrin/Radixin/Moesin-directed Subcellular Targeting
J. Biol. Chem.,
March 15, 2002;
277(12):
10400 - 10409.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Itoh, M. Sakakibara, S. Yamasaki, A. Takeuchi, H. Arase, M. Miyazaki, N. Nakajima, M. Okada, and T. Saito
Cutting Edge: Negative Regulation of Immune Synapse Formation by Anchoring Lipid Raft to Cytoskeleton Through Cbp-EBP50-ERM Assembly
J. Immunol.,
January 15, 2002;
168(2):
541 - 544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Algeciras-Schimnich, L. Shen, B. C. Barnhart, A. E. Murmann, J. K. Burkhardt, and M. E. Peter
Molecular Ordering of the Initial Signaling Events of CD95
Mol. Cell. Biol.,
January 1, 2002;
22(1):
207 - 220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Lange
Role of microvillar cell surfaces in the regulation of glucose uptake and organization of energy metabolism
Am J Physiol Cell Physiol,
January 1, 2002;
282(1):
C1 - C26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. L. Bonilha and E. Rodriguez-Boulan
Polarity and Developmental Regulation of Two PDZ Proteins in the Retinal Pigment Epithelium
Invest. Ophthalmol. Vis. Sci.,
December 1, 2001;
42(13):
3274 - 3282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Vaiskunaite, T. Kozasa, and T. A. Voyno-Yasenetskaya
Interaction between the Galpha Subunit of Heterotrimeric G12 Protein and Hsp90 Is Required for Galpha 12 Signaling
J. Biol. Chem.,
November 30, 2001;
276(49):
46088 - 46093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Lockwich, B. B. Singh, X. Liu, and I. S. Ambudkar
Stabilization of Cortical Actin Induces Internalization of Transient Receptor Potential 3 (Trp3)-associated Caveolar Ca2+ Signaling Complex and Loss of Ca2+ Influx without Disruption of Trp3-Inositol Trisphosphate Receptor Association
J. Biol. Chem.,
November 2, 2001;
276(45):
42401 - 42408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O.-M. Mykkanen, M. Gronholm, M. Ronty, M. Lalowski, P. Salmikangas, H. Suila, and O. Carpen
Characterization of Human Palladin, a Microfilament-associated Protein
Mol. Biol. Cell,
October 1, 2001;
12(10):
3060 - 3073.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Weiner, N. Fukushima, J. J. A. Contos, S. S. Scherer, and J. Chun
Regulation of Schwann Cell Morphology and Adhesion by Receptor-Mediated Lysophosphatidic Acid Signaling
J. Neurosci.,
September 15, 2001;
21(18):
7069 - 7078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Ward IV, L. Schweizer, R. S. Lamb, and R. G. Fehon
The Protein 4.1, Ezrin, Radixin, Moesin (FERM) Domain of Drosophila Coracle, a Cytoplasmic Component of the Septate Junction, Provides Functions Essential for Embryonic Development and Imaginal Cell Proliferation
Genetics,
September 1, 2001;
159(1):
219 - 228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. ORLANDO, T. TAKEDA, B. ZAK, S. SCHMIEDER, V. M. BENOIT, T. MCQUISTAN, H. FURTHMAYR, and M. G. FARQUHAR
The Glomerular Epithelial Cell Anti-Adhesin Podocalyxin Associates with the Actin Cytoskeleton through Interactions with Ezrin
J. Am. Soc. Nephrol.,
August 1, 2001;
12(8):
1589 - 1598.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Bame
Heparanases: endoglycosidases that degrade heparan sulfate proteoglycans
Glycobiology,
June 1, 2001;
11(6):
91R - 98R.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. V. Melendez-Vasquez, J. C. Rios, G. Zanazzi, S. Lambert, A. Bretscher, and J. L. Salzer
Nodes of Ranvier form in association with ezrin-radixin-moesin (ERM)-positive Schwann cell processes
PNAS,
January 30, 2001;
98(3):
1235 - 1240.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-G. Koh, E. Manser, Z.-S. Zhao, C.-P. Ng, and L. Lim
{beta}1PIX, the PAK-interacting exchange factor, requires localization via a coiled-coil region to promote microvillus-like structures and membrane ruffles
J. Cell Sci.,
January 12, 2001;
114(23):
4239 - 4251.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Pierreux, F. J. Nicolás, and C. S. Hill
Transforming Growth Factor beta -Independent Shuttling of Smad4 between the Cytoplasm and Nucleus
Mol. Cell. Biol.,
December 1, 2000;
20(23):
9041 - 9054.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D G. R Evans, M Sainio, and M. E Baser
Neurofibromatosis type 2
J. Med. Genet.,
December 1, 2000;
37(12):
897 - 904.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. J. Weinman, C. Minkoff, and S. Shenolikar
Signal complex regulation of renal transport proteins: NHERF and regulation of NHE3 by PKA
Am J Physiol Renal Physiol,
September 1, 2000;
279(3):
F393 - F399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Schaller
UNC112: A New Regulator of Cell-Extracellular Matrix Adhesions?
J. Cell Biol.,
July 11, 2000;
150(1):
F9 - F12.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Berg, B. Derfler, C. Pennisi, D. Corey, and R. Cheney
Myosin-X, a novel myosin with pleckstrin homology domains, associates with regions of dynamic actin
J. Cell Sci.,
January 10, 2000;
113(19):
3439 - 3451.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C Wadham, J. Gamble, M. Vadas, and Y Khew-Goodall
Translocation of protein tyrosine phosphatase Pez/PTPD2/PTP36 to the nucleus is associated with induction of cell proliferation
J. Cell Sci.,
January 9, 2000;
113(17):
3117 - 3123.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Q. Sun, M. Yamamoto, M. Mejillano, and H. L. Yin
Gelsolin, a Multifunctional Actin Regulatory Protein
J. Biol. Chem.,
November 19, 1999;
274(47):
33179 - 33182.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Nix, A. H. Chishti, J. M. Anderson, and Z. Walther
hCASK and hDlg Associate in Epithelia, and Their Src Homology 3 and Guanylate Kinase Domains Participate in Both Intramolecular and Intermolecular Interactions
J. Biol. Chem.,
December 22, 2000;
275(52):
41192 - 41200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Kussel-Andermann, A. El-Amraoui, S. Safieddine, J.-P. Hardelin, S. Nouaille, J. Camonis, and C. Petit
Unconventional Myosin VIIA Is a Novel A-kinase-anchoring Protein
J. Biol. Chem.,
September 15, 2000;
275(38):
29654 - 29659.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Nguyen, D. Reczek, and A. Bretscher
Hierarchy of Merlin and Ezrin N- and C-terminal Domain Interactions in Homo- and Heterotypic Associations and Their Relationship to Binding of Scaffolding Proteins EBP50 and E3KARP
J. Biol. Chem.,
March 2, 2001;
276(10):
7621 - 7629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Gisler, I. Stagljar, M. Traebert, D. Bacic, J. Biber, and H. Murer
Interaction of the Type IIa Na/Pi Cotransporter with PDZ Proteins
J. Biol. Chem.,
March 16, 2001;
276(12):
9206 - 9213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Broustas, N. Grammatikakis, M. Eto, P. Dent, D. L. Brautigan, and U. Kasid
Phosphorylation of the Myosin-binding Subunit of Myosin Phosphatase by Raf-1 and Inhibition of Phosphatase Activity
J. Biol. Chem.,
January 18, 2002;
277(4):
3053 - 3059.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ivetic, J. Deka, A. Ridley, and A. Ager
The Cytoplasmic Tail of L-selectin Interacts with Members of the Ezrin-Radixin-Moesin (ERM) Family of Proteins. CELL ACTIVATION-DEPENDENT BINDING OF MOESIN BUT NOT EZRIN
J. Biol. Chem.,
January 11, 2002;
277(3):
2321 - 2329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Diakonova, G. Bokoch, and J. A. Swanson
Dynamics of Cytoskeletal Proteins during Fcgamma Receptor-mediated Phagocytosis in Macrophages
Mol. Biol. Cell,
February 1, 2002;
13(2):
402 - 411.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|